Medical News

RSS

Medicare Advantage plans marked by shortcomings

The New York Times reports that these problem areas include rejection of claims for medical services and limits on prescription drug coverage. News outlets also report on ACOs grades and Medicare Advantage rate shifts.

14 Oct 2014

Tackling poor oral health among athletes

Poor oral health affecting athletes' general health and performance shows 'no signs of improvement' and must be remedied, say a group of UCL-led health experts and sporting bodies. In a consensus statement published in the British Journal of Sports Medicine, the authors call for action to tackle poor oral health among athletes.

14 Oct 2014

New research shows impact of ulcerative colitis on patients' quality of life, treatment satisfaction

New research shows that the majority of patients with the challenging inflammatory bowel disease, ulcerative colitis (UC), state that the three biggest impacts of the disease on their lives are on their emotional state (in terms of depression, anger or anxiety levels) (76%), ability to get adequate rest/sleep (75%), and taking sick days off work (70%). Those who have had a colectomy (removal of the colon) were more likely to suffer from these impacts.

14 Oct 2014

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

Providing increased services for Chronic Fatigue Syndrome sufferers will be the focus of Griffith research following the award of a $1.85m grant to one of Australia’s foremost authorities on the condition.

14 Oct 2014

Childhood obesity rates still high in Ireland and may begin to fall, say researchers

Childhood overweight and obesity rates have plateaued in primary school aged children in the Republic of Ireland, reveals research published today in the open access journal BMC Public Health. The study found that although obesity rates remain high, there is evidence that they have stabilised and may be beginning to fall.

14 Oct 2014

Medicaid backlogs persist, raising concerns as enrollment season nears

The Wall Street Journal reports that hundreds of thousands of people still don't officially have the Medicaid coverage they signed up for. Some of them began the process in late 2013. In other Medicaid news, debate in Mississippi continues regarding whether the state should pursue the expansion of the health insurance program for low-income and disabled people.

14 Oct 2014

Penn State scientists find that mitochondrial disease more prevalent in older moms

The discovery of a "maternal age effect" by a team of Penn State scientists that could be used to predict the accumulation of mitochondrial DNA mutations in maternal egg cells -- and the transmission of these mutations to children -- could provide valuable insights for genetic counseling.

14 Oct 2014

Improper splinting can lead to swelling and other skin complications

More than 90 percent of potential pediatric fractures are splinted improperly in emergency rooms and urgent care centers, which can lead to swelling and skin injuries, according to a study by researchers at the University of Maryland School of Medicine.

14 Oct 2014

Fla.'s gubernatorial candidates at odds over Medicaid expansion

Charlie Crist, the Republican-turned-Democrat, says he will consider using an executive order to expand the program for low-income Floridians.

14 Oct 2014

VisionCare's Implantable Miniature Telescope gets FDA approval for treating end-stage AMD

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration approved the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration who are age 65 or older.

14 Oct 2014

C3BS receives authorization to begin CHART-1 European Phase III trial for C-Cure in Switzerland

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today it has received authorization from Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C-Cure in Switzerland.

14 Oct 2014

FDA approves new hepatitis C drug, Harvoni

Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.

14 Oct 2014

Kenneth Rainin Foundation grants $2.2 million for Inflammatory Bowel Disease research

The Kenneth Rainin Foundation announced today that it will grant $2.2 million to scientists to conduct Inflammatory Bowel Disease (IBD) research. The Rainin Foundation offers support for cutting-edge projects that typically are not eligible for funding from more traditional sources due to their ground-breaking, pioneering nature.

14 Oct 2014

Eye Co receives patent for new class of eye disease drugs

Australian ocular technology company Eye Co Pty Ltd has achieved a key commercial milestone, with a patent granted protecting its new class of eye disease drugs throughout the high value European market.

14 Oct 2014

Preventing cancer: an interview with Dr Fiona Reddington

It’s estimated that more than four in 10 cancer cases could be prevented by lifestyle changes, such as not smoking, keeping a healthy body weight, cutting back on alcohol, eating a healthy diet, keeping active and staying safe in the sun.

13 Oct 2014

Bone mineral density not linked to musculoskeletal pain

Bone mineral density does not contribute to musculoskeletal pain, researchers report in findings that shed light on the controversy over whether osteoporosis is a painless disease.

13 Oct 2014

Pain classification with VAS scores ‘doubtful’

Researchers advise caution when using cutoff points on the visual analogue scale (VAS) to classify mild, moderate or severe pain in clinical practice.

13 Oct 2014

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

13 Oct 2014

National Psoriasis Foundation to hold free psoriatic arthritis program in Seattle

If you're one of the roughly 28,000 Seattle metro residents struggling with pain from psoriatic arthritis (PsA)—an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons—learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at the Double Tree Suites Southcenter on November 8.

13 Oct 2014

Parkinson's disease can migrate from gut to brain, shows research

Parkinson's disease is strongly linked to the degeneration of the brain's movement center. In the last decade, the question of where the disease begins has led researchers to a different part of the human anatomy.

13 Oct 2014

Medical News

Medicare Advantage plans marked by shortcomings

Tackling poor oral health among athletes

New research shows impact of ulcerative colitis on patients' quality of life, treatment satisfaction

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

Childhood obesity rates still high in Ireland and may begin to fall, say researchers

Medicaid backlogs persist, raising concerns as enrollment season nears

Penn State scientists find that mitochondrial disease more prevalent in older moms

Improper splinting can lead to swelling and other skin complications

Fla.'s gubernatorial candidates at odds over Medicaid expansion

VisionCare's Implantable Miniature Telescope gets FDA approval for treating end-stage AMD

C3BS receives authorization to begin CHART-1 European Phase III trial for C-Cure in Switzerland

FDA approves new hepatitis C drug, Harvoni

Kenneth Rainin Foundation grants $2.2 million for Inflammatory Bowel Disease research

Eye Co receives patent for new class of eye disease drugs

Preventing cancer: an interview with Dr Fiona Reddington

Bone mineral density not linked to musculoskeletal pain

Pain classification with VAS scores ‘doubtful’

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

National Psoriasis Foundation to hold free psoriatic arthritis program in Seattle

Parkinson's disease can migrate from gut to brain, shows research

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News